Skip to main content
Fresenius SE & Co. KGaA logo

Fresenius SE & Co. KGaA — Investor Relations & Filings

Ticker · FRE ISIN · DE0005785604 LEI · XDFJ0CYCOO1FXRFTQS51 F Human health and social work activities
Open in API
Filings indexed 1,398 across all filing types
Latest filing 2007-06-06 Director's Dealing
Country DE Germany
Listing F FRE

About Fresenius SE & Co. KGaA

https://www.fresenius.com/

Fresenius SE & Co. KGaA is a global healthcare company that provides system-critical products and services for leading therapies for the care of critically and chronically ill patients. The company's portfolio encompasses a wide range of products and services for dialysis, hospitals, and outpatient medical care. Key offerings include intravenously administered generic drugs, biopharmaceuticals, biosimilars, clinical nutrition, and infusion therapies. Additionally, the company operates a large network of private hospitals and outpatient centers. Through its strategic investment in Fresenius Medical Care, it is a leading global provider of products and services for individuals with renal diseases.

Recent filings

Filing Released Lang Actions
DGAP-DD: Fresenius AG english
Director's Dealing Classification · 100% confidence The document text explicitly contains the header "Directors’ Dealings" and details a transaction (exercise of stock options) by a person in a managerial responsibility position ('Member of an administrative or supervisory body'). This directly corresponds to the definition of Director's Dealing, which is classified under the code DIRS.
2007-06-06 English
DGAP-DD: Fresenius AG english
Director's Dealing Classification · 100% confidence The document explicitly uses the header "Directors’ Dealings" and details a transaction made by a person in a managerial responsibility position ("Krick, Gerd, Position: Member of an administrative or supervisory body"). The content describes the exercise of options for Fresenius AG ordinary shares. This directly matches the definition for Director's Dealing (DIRS). The document length is short (1191 chars), but the content is the actual transaction report, not an announcement of a report's publication.
2007-06-06 English
Fresenius AG: Release according to Article 26a, Section 1 WpHG [Securities Trading Act] with the aim of a Europe-wide distribution
Declaration of Voting Results & Voting Rights Announcements Classification · 100% confidence The document is titled 'Total Voting Rights announcement' and explicitly states the total number of voting rights as of May 31, 2007, referencing Article 26a, Section 1 WpHG (German Securities Trading Act). This type of announcement, which reports on the total number of shares carrying voting rights, is a specific regulatory disclosure. Among the provided definitions, none perfectly match 'Total Voting Rights Announcement'. However, it is a formal regulatory disclosure concerning share structure/rights. It is not an AGM result (DVA), Director's Dealing (DIRS), or a general share change (SHA/POS). Given its nature as a mandatory, specific regulatory disclosure that doesn't fit the other precise categories, the most appropriate fallback is Regulatory Filings (RNS). The document length is very short (1120 chars) and it is a direct announcement of a specific metric, not a comprehensive report.
2007-05-31 English
Presentation: Bank of America Health Care Conference
Investor Presentation Classification · 98% confidence The document text is structured like a presentation, featuring slides, section headers (e.g., "Fresenius Group: Excellent Start into 2007"), financial outlooks for 2007, and detailed tables comparing Q1 2007 results against Q1 2006 results for various segments (Fresenius Kabi, Fresenius ProServe). The content focuses heavily on performance metrics, guidance, and segment breakdowns, which is characteristic of an Investor Presentation (IP) or a presentation given at a conference (like the 'Bank of America, 2007 Health Care Conference' mentioned at the start). Since it is a detailed presentation format, Investor Presentation (IP) is the most appropriate classification over a brief Fund Factsheet (FS) or a full Earnings Release (ER) which usually contains less graphical detail and more narrative summary.
2007-05-30 English
DGAP-DD: Fresenius AG english
Director's Dealing Classification · 100% confidence The document explicitly uses the header "Directors’ Dealings" and details a transaction made by a person in a managerial position ("Position: Member of an administrative or supervisory body"). The content describes the exercise of stock options by Gerd Krick of Fresenius AG. This directly matches the definition for Director's Dealing (DIRS). The reference to section 15a of the WpHG further confirms this is a mandatory disclosure of insider transactions.
2007-05-24 English
DGAP-DD: Fresenius AG english
Director's Dealing Classification · 100% confidence The document explicitly uses the header 'Directors’ Dealings' and details transactions made by a person in a managerial role ('Position: Member of an administrative or supervisory body'). It reports the exercise of stock options by Gerd Krick of Fresenius AG. This directly corresponds to the definition of Director's Dealing (insider trades by executives/directors), which maps to the filing code DIRS.
2007-05-24 English

Browse filings by year

31 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.